ODDITY Announces New $200 Million Credit Facility
GlobeNewswire· 2025-02-01 05:05
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- On January 31, 2025, ODDITY Tech Ltd. (NASDAQ: ODD, the “Company”) entered into agreements with a syndicate of banks to secure credit facilities for a total of $200 million (collectively the “Facility”). The Facility replaces the Company’s previous $100 million credit facility and increases financial flexibility to fund growth initiatives, acquisitions, share buybacks, and other general corporate needs. ODDITY remains in a strong financial position, with over $165 ...
Hepsiburada Announces Voting Results of the Extraordinary General Assembly Meeting, New Board Committees Composition and the Appointment of a General Counsel and Corporate Secretary
GlobeNewswire· 2025-02-01 05:05
文章核心观点 土耳其领先的电子商务平台Hepsiburada宣布2025年1月31日股东大会特别会议投票结果、董事会委员会新组成以及总法律顾问兼公司秘书的任命 [1] EGM投票结果 - 股东大会根据土耳其商法典和相关规定召开,出席会议的股东以多数票决定了相关事项 [2] 董事会委员会组成变更 - 批准选举Mikheil Lomtadze、Tengiz Mosidze等6人为董事会成员,Tayfun Bayazıt、Ahmet Fadıl Ashaboğlu等3人为独立董事,任期至2027年1月31日,董事会成员总数从11人减至9人 [4] - 任命Mikheil Lomtadze为董事会主席,Yuri Didenko为副主席 [4] - 批准对公司章程的多项修订,反映A类股份特权终止 [4] - 新任命的董事会确定了各委员会组成,包括审计委员会、风险早期检测委员会和公司治理委员会 [5][10] 总法律顾问兼公司秘书任命 - 2025年1月24日,董事会任命Güneş Akman Özcan自2025年1月1日起正式担任总法律顾问兼公司秘书 [6] 公司介绍 - Hepsiburada是土耳其领先的电子商务技术平台,采用混合模式运营,拥有约10万家商户 [9] - 公司愿景是引领商业数字化,为商家和消费者提供广泛服务,其集成金融科技平台Hepsipay提供安全支付解决方案 [10][11] - 自2000年成立以来,公司致力于通过数字能力赋能土耳其女性经济,2017年推出相关项目支持近5.75万名女性企业家 [12]
DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of NorthBay Healthcare Corporation Customers Whose Data May Have Been Compromised
GlobeNewswire· 2025-02-01 05:04
NEWTOWN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations by NorthBay Healthcare Corporation. NorthBay Health learned of suspicious activity on its network on February 23, 2024. To join this case, go HERE. About NorthBay Healthcare Corporation NorthBay Health is a nonprofit healthcare provider dedicated to serving the Solano County, California community. What happened? On or about February 23, 2024, North ...
FutureFuel Announces Certain Matters with Respect to Its Biodiesel Production
Newsfilter· 2025-02-01 05:02
CLAYTON, Mo., Jan. 31, 2025 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE:FF) ("FutureFuel" or the "Company"), a manufacturer of custom and performance chemicals and biofuels, today announced certain matters with respect to its Biodiesel production. FutureFuel initiated its scheduled annual maintenance and turnaround of its Biodiesel plant at the end of December 2024. This turnaround has proven more extensive than expected. Therefore, the Company currently believes the turnaround will continue through Februa ...
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
Newsfilter· 2025-02-01 05:01
DUBLIN, Jan. 31, 2025 (GLOBE NEWSWIRE) -- GH Research PLC (NASDAQ:GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today announced that it will host a conference call and live webcast on Monday, February 3, 2025, at 8.00 a.m. EST to provide an update on data from the randomized, double-blind, placebo-controlled Phase 2b trial of GH001 in treatment-resistant depression (TRD). To access the conference call, please register in ...
Capital Southwest Announces U.S. Federal Income Tax Treatment of 2024 Dividends
Newsfilter· 2025-02-01 05:01
DALLAS, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Capital Southwest Corporation ("Capital Southwest" or the "Company") (NASDAQ:CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, announced today the U.S. federal income tax treatment of its 2024 dividends. U.S. Federal Income Tax Treatment of 2024 Dividends Capital Southwest paid dividends totaling $2.53 per share that are attributable to the ta ...
PSNY INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Polestar Automotive Holding UK PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire· 2025-02-01 05:00
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Polestar Automotive Holding UK PLC (“Polestar” or “the Company”) (NASDAQ: PSNY) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise a ...
Tesla: Once Again, It's Time To Trim (Double Rating Downgrade)
Seeking Alpha· 2025-02-01 04:59
分组1 - 公司对特斯拉的研究业绩感到自豪 [1] 分组2 - 公司专注为个人投资者寻找高收益投资机会 [2] - 公司凭借专业自营交易背景将复杂概念简单化并提供清晰可行建议以助投资者获得更好回报 [2] - 公司的分析旨在助投资者在市场做明智决策且有独家专业研究支持 [2]
Vislink Announces Delisting from Nasdaq and Potential SEC Deregistration
GlobeNewswire· 2025-02-01 04:58
Mt. Olive, NJ, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (Nasdaq: VISL) (“Vislink” or the “Company”), a global technology leader in the capture, delivery, and management of high-quality, live video and associated data in the media and entertainment, public safety, and defense markets, today announced that it has provided notification to The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to voluntarily delist the Company’s common stock, par value $0.00001 per share (the “Common Stock”), ...
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – REGN
GlobeNewswire· 2025-02-01 04:56
NEW YORK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), of the important March 10, 2025 lead plaintiff deadline. SO WHAT: If you purchased Regeneron securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency f ...